Browse our products

Want to know more?
Reach out to our team to know more about the product or how to purchase
Get more information

Fujirebio INNO-LIPA® HBV Multi-DR

Minimise treatment failure, Maximise long-term HBV suppression.

Line probe assay for simultaneous detection of hepatitis B virus wild-type motif, lamivudine, telbivudine, emtricitabine, adefovir, and entecavir resistance-associated mutations.

Features & Benefits

  • Earliest detection of mutants: 
  • Highly sensitive detection at single nucleotide level of mixtures of wild-type and mutants, identifying the appearance of mutants earlier than sequencing and viral load assays 
  • Lower limit of detection of 990 copies/ml 
  • Allowing rapid and effective HBV suppression by early adoption to the most suited therapy 
  • All the necessary information in one assay: 
  • Allows simultaneous detection of all clinically relevant HBV polymerase wild-type and drug-induced mutations associated with lamivudine, emtricitabine, telbivudine, adefovir and tenofovir resistance as well as known compensatory mutations (codons 80, 173, 180, 181, and 204) 
  • Identifies amino acid changes in the overlapping reading frame of HBsAg (codons 171, 172, 195, 196, 198, and 199) 
  • Optimised for 8 known HBV genotypes (A-H) 
  • Low chance of errors and limited hands-on time: 
  • Easy to perform and robust assay 
  • Amplicon can also be used for INNO-LIPA HBV GT 
  • Fully automated processing of the strips possible with TENDIGO®, Auto-LIPA™ 48 and AutoBlot 3000H. 
  • Objective and automated reading and interpretation of strips possible using LiRAS® for Infectious Diseases.

For more information, visit

Related Products

    Receive our newsletter to get the latest news about our products and services

    * indicates required

    By signing up to our newsletter, you agree to our Data Privacy Policy.
    Getz Healthcare shares your commitment to achieving the best possible patient outcomes by connecting healthcare professionals with the finest medical technologies and supplies in the market.
    By continuing, you are acknowledging that you are a registered healthcare professional with a valid certification.

    No, I Disagree